Central Nervous System PRN Focus Session — Caution! Baby on Board! Treatment Recommendations for Bipolar Disorders in Patients Who Are Pregnant
Saturday, November 11, 2023 from 1:45 PM to 3:15 PM CST at Lone Star Ballroom C2
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-23-127-L01-P
Activity Type: An Application-Based Activity
The Central Nervous System (CNS) PRN Educational Programming Committee presents an education session focused on the use of psychiatric medications for bipolar disorder in pregnant patients. Specific topics will include: 1) a discussion of pharmacokinetic and dynamic changes and risk- benefit analysis of utilizing psychiatric medications in pregnant patients with bipolar disorder, 2) a review of current guideline recommendations and recent literature describing the use of psychiatric medications in pregnant patients with bipolar disorder and phase of care considerations, and 3) evidence based recommendations for medication use in bipolar disorder as patients transition through the stages of pregnancy. The target audience of this session is practicing pharmacists, pharmacy residents, pharmacy students, and associated medical professionals. The purpose of this session is to deliver education for an evolving, relevant issue to enhance pharmacist understanding and readiness in application to the clinical setting.
Faculty
 | Moderator: Jason Chau, Pharm.D., BCACP, BCPS, MSCS
Title: Central Nervous System PRN Focus Session — Caution! Baby on Board! Treatment Recommendations for Bipolar Disorders in Patients Who Are Pregnant
Institution: Optum
City/State: Tacoma, WA |
Learning Objectives
1. Compare and contrast the pharmacokinetic and pharmacodynamic changes that occur during pregnancy.
2. Analyze the efficacy, risks, and benefits of withholding or utilizing psychiatric medications for bipolar disorder during the prenatal and peripartum periods.
3. Evaluate current guideline recommendations and recent literature describing the use of psychiatric medications in pregnant patients living with a bipolar disorder.
4. Design an evidence-based treatment regimen for a pregnant patient living with a bipolar disorder, balancing risks and benefits for both mother and fetus.
5. Create an appropriate therapeutic monitoring plan across the continuum of pregnancy.
Medication Kinetic, Dynamic and Safety Challenges in Bipolar Disorders Treatment During Pregnancy1:45 PM to 2:15 PM  | Speaker: Ema Ferreira, Pharm.D., B.S.Pharm, MPH
Title: Medication Kinetic, Dynamic and Safety Challenges in Bipolar Disorders Treatment During Pregnancy
Institution: Ste-Justine Hospital/Faculté de pharmacie, Université de Montréal
City/State: Montreal, QC
View Biography |
|
Current Bipolar Disorders Treatment Recommendations in Patients who are Pregnant2:15 PM to 2:45 PM  | Speaker: Stephanie D. Nichols, Pharm.D., MPH, BCPP
Title: Current Bipolar Disorders Treatment Recommendations in Patients who are Pregnant
Institution: University of New England
City/State: Saco, ME
View Biography |
|
Real-World Clinical Approaches and Considerations in the Treatment of Bipolar Disorders in Patients Who are Pregnant2:45 PM to 3:15 PM  | Speaker: Alicia B. Forinash, Pharm.D., FCCP, BCACP, BCPS
Title: Real-World Clinical Approaches and Considerations in the Treatment of Bipolar Disorders in Patients Who are Pregnant
Institution: St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy
City/State: Saint Louis, MO
View Biography |
|